Using advanced MRI analysis to improve diagnosis and treatment of multiple sclerosis
Advanced Statistical Analytics of MRI in MS
This study is looking at ways to better understand and treat multiple sclerosis by using advanced techniques to analyze MRI scans, helping doctors identify and understand the different types of lesions in MS patients more clearly.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pennsylvania NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-10802294 on NIH RePORTER |
What this research studies
This research focuses on enhancing the diagnosis and treatment of multiple sclerosis (MS) through advanced statistical analysis of MRI scans. By extracting detailed imaging data related to the pathophysiology of MS, the study aims to identify and characterize individual lesions more accurately. This approach seeks to overcome current challenges in understanding the heterogeneity of lesions, which can complicate diagnosis and treatment decisions. Ultimately, the goal is to improve clinical outcomes and facilitate more effective therapeutic trials for MS patients.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with multiple sclerosis who are undergoing MRI scans as part of their clinical care.
Not a fit: Patients without a diagnosis of multiple sclerosis or those who do not undergo MRI scans may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to earlier and more accurate diagnoses of multiple sclerosis, improving treatment options and outcomes for patients.
How similar studies have performed: Previous research has shown promise in using advanced imaging techniques for better understanding and treatment of neurological conditions, indicating potential success for this novel approach.
Where this research is happening
Philadelphia, United States
- University of Pennsylvania — Philadelphia, United States (Active)
Researchers
- Principal investigator: Shinohara, Russell Takeshi — University of Pennsylvania
- Study coordinator: Shinohara, Russell Takeshi
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.